Agilent Technologies, Inc. (BIT:1A)
Italy · Delayed Price · Currency is EUR | Market Cap | 43.35B +27.4% |
| Revenue (ttm) | 6.41B +8.6% |
| Net Income | 1.25B +18.0% |
| EPS | 4.41 +18.4% |
| Shares Out | n/a |
| PE Ratio | 34.63 |
| Forward PE | 26.26 |
| Dividend | 0.89 (0.59%) |
| Ex-Dividend Date | Oct 5, 2026 |
| Volume | 2 |
| Open | 150.70 |
| Previous Close | 151.35 |
| Day's Range | 150.70 - 151.10 |
| 52-Week Range | 93.92 - 155.35 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 25, 2026 |
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti... [Read more]
Financial Performance
In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.
Financial numbers in USD Financial StatementsNews
Agilent price target raised to $196 from $180 at TD Cowen
TD Cowen raised the firm’s price target on Agilent (A) to $196 from $180 and keeps a Buy rating on the shares. The firm adjusted targets in the life science…
Agilent to acquire Proscia in all-cash transaction valued at $240M
Agilent (A) Technologies announced it has entered into a definitive agreement to acquire Proscia, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash tran...
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
SANTA CLARA, Calif. & PHILADELPHIA--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology...
Agilent price target raised to $190 from $175 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Agilent (A) to $190 from $175 and keeps an Overweight rating on the shares as the firm refreshed models in its life…
Agilent price target raised to $190 from $180 at BofA
BofA raised the firm’s price target on Agilent (A) to $190 from $180 and keeps a Buy rating on the shares. The life science tools sector has further re-rated since…
Agilent Technologies Slides: Corporate presentation
Agilent Technologies has posted slides in relation to its latest quarterly earnings report, which was published on October 8, 2026.
Agilent price target raised to $195 from $175 at Barclays
Barclays raised the firm’s price target on Agilent (A) to $195 from $175 and keeps an Overweight rating on the shares. The firm adjusted targets in the life science and…
Agilent launches NovoStation Sample Preparation System
Agilent (A) Technologies announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample prepara...
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratorie...
Agilent launches Agilent BioTek Gen5 AI cell identification module
Agilent (A) Technologies announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmenta...
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that...
Agilent Technologies Transcript: U.S. All Stars Conference
Ignite transformation has driven growth, margin expansion, and innovation, focusing on autonomous labs and AI. China and Asia ex-China are key growth regions. LC/GC replacement cycles and service contracts support recurring revenue. Specialty CDMO targets mid-teens growth with new capacity in 2027. Disciplined capital allocation and targeted M&A support expansion.
Agilent launches TapeStationDx systems for NGS sample quality control
Agilent (A) Technologies announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company’s automated electrop...
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStation...
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of...
Agilent Announces Cash Dividend of 25.5 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on October 6...
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. Al...
Agilent assumed with a Neutral at UBS
UBS assumed coverage of Agilent (A) with a Neutral rating and $165 price target Organic growth has recovered and should support 6% revenue and 10%+ EPS growth in FY27, but…
Agilent announces retirement of board chair Koh Boon Hwee
Agilent (A) Technologies announced that Koh Boon Hwee, independent chair of the company’s board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of…
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Se...
Agilent announces U.S. launch of Agilent S540MD Slide Scanner System
Agilent (A) Technologies announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging digital scanner, following FDA clearance. The company said, “Engineered for speed a...
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, follo...
Agilent quarterly filing raises questions, says Jefferies
Jefferies says Agilent’s (A) fiscal Q3 filing includes color that described a significant decline for its liquid chromatography-mass spectrometry equipment in America while Europe also saw declines. T...
Agilent announces launch of Agilent Cary 635 FTIR spectrometer
Agilent (A) Technologies announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared analysis. The company said, “Co...
Agilent Introduces the Cary 635 FTIR Spectrometer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fo...